Management of Pulmonary Tuberculosis Lost to Follow-Up

Immediate Actions for Patient Re-engagement

The American Thoracic Society recommends deploying outreach workers to conduct field and home visits to locate the patient and assess reasons for treatment interruption 1, 2
Assign a public health case manager to develop an individualized case management plan addressing specific barriers identified, such as transportation, housing instability, substance abuse, and language barriers 2
Implement reminder systems and aggressive follow-up protocols for all missed appointments going forward 1, 2
Provide transportation vouchers to facilitate clinic attendance 1
Offer incentives such as food stamps, meals, or restaurant/grocery coupons 1
Arrange convenient clinic hours and locations with personnel who speak the patient's language 1
Provide social service assistance including referrals for substance abuse treatment, housing assistance, and other identified needs 1, 2

Collect sputum specimens for AFB smear and culture immediately to assess current disease status and treatment response, as recommended by the American Thoracic Society 1, 3
Obtain chest radiograph to evaluate for radiographic improvement or progression 1, 4
Perform drug susceptibility testing for isoniazid, rifampin, ethambutol, and pyrazinamide if not previously done or if treatment failure is suspected 1, 3
Assess total duration of treatment interruption and calculate remaining treatment needed 2, 3

If the patient has been off treatment for less than 2 months and had documented adherence before interruption, resume the original regimen and extend total treatment duration by the length of interruption, as recommended by the American Thoracic Society 2, 3
If treatment interruption exceeds 2 months or if cultures remain positive after 3 months of cumulative therapy, presume treatment failure and collect specimens for culture and drug susceptibility testing before modifying therapy 3, 5
Never add a single drug to a failing regimen, as this leads to acquired resistance; instead, add at least three new drugs to which susceptibility can be inferred 3, 5, 6
For seriously ill patients or those with positive AFB smears, start empirical retreatment immediately without waiting for drug susceptibility results 3, 5

Reinitiate or intensify directly observed therapy (DOT) for all patients lost to follow-up, as this is the most effective method to ensure adherence and prevent further treatment interruption, according to the Centers for Disease Control and Prevention 1, 2
Monitor sputum cultures monthly until two consecutive specimens are culture-negative 1, 5
Assess adherence and monitor for improvement in TB symptoms at each visit 1
Monitor weight monthly and adjust medication doses as needed 1

Consult with or refer to a TB specialist or specialized treatment center if multidrug-resistant TB is suspected (resistance to at least isoniazid and rifampin), as recommended by the World Health Organization 3, 5
Expert consultation is recommended for all complex cases of treatment failure or drug resistance 3, 5

Failing to conduct aggressive outreach and assuming the patient will return on their own 1, 2
Adding only one drug to a failing regimen, which rapidly leads to acquired resistance 3, 5, 6
Delaying empirical retreatment in seriously ill patients while waiting for drug susceptibility results 3, 5
Not collecting specimens for culture and drug susceptibility testing before changing therapy 3, 5, 6
Underestimating the importance of enablers and incentives in maintaining adherence after re-engagement 1, 2
Failing to extend total treatment duration to account for the interruption period 2, 3